AlzeCure Pharma places 9,926,099 shares with QuantumCell at SEK 4.91 each

Reuters2026/08/03 06:07

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

AlzeCure Pharma set a directed share issue to QuantumCell as part of the ACD856 out-licensing and collaboration agreement.
QuantumCell will subscribe for 9,926,099 new shares at SEK 4.91 each, paid in cash.
The placement implies about 6.7% dilution; total shares to rise to 147,823,445 once registered.
The transaction corresponds to a USD 5 million equity component previously disclosed under the agreement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AlzeCure Pharma AB published the original content used to generate this news brief on August 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

AlzeCure Pharma places 9,926,099 shares with QuantumCell at SEK 4.91 each

You may also like

Crypto prices